Click to see video in chapters
Learning Objectives
- Discuss and review the SPRINT study results. Should we all be SPRINTing?
- Evaluate the latest evidence on RAS blockers in mono therapy and in combination with diuretics
- Gain an understanding of the changes to the CHEP guidelines, based on the SPRINT study results
Chair
Peter J Lin
MD, CCFP
Director, Primary Care Initiative
Canadian Heart Research Centre Medical
Director, LinCorp Medical Inc.
Faculty
Subodh Verma
MD, PhD, FRCSC, FAHA
Division of Cardiac Surgery, St. Michael’s Hospital
Professor of Surgery, Pharmacology & Toxicology, University of Toronto
Canada Research Chair in Atherosclerosis
Philip A McFarlane
MD, PhD, FRCPC
Medical Director of Home Dialysis
Medical Co-Director, Multidisciplinary Diabetes Complications Clinic
Chief Nephrologist, Live Kidney Donor Program, St. Michael’s Hospital
Assistant Professor of Medicine, University of Toronto
Sheldon Tobe
MD, MScCH (HPTE), FRCPC, FACP, FASH
Nephrologist, Sunnybrook Health Sciences Centre
Associate Scientist, Sunnybrook Research Institute Professor of Medicine, University of Toronto and Northern Ontario School of Medicine
HSF/NOSM Chair of Aboriginal and Rural Health Research
Video Information
- Credit:No Credit Available
- Post Date:July 28, 2016
- Expiry Date:N/A
